EHS - EUON
Health - Overview - EHS - Text Web Content
In the health-related nanotechnology, the drivers for innovation and market development are mainly linked to the possible economic and therapeutic impact and the perceived societal needs that may be met by the application of this new technology in pharmaceuticals and medical devices. Some nanotechnologies appear useful in reducing the effect on the environment of what previously were considered to be undesirable chemicals.
A constraint to the development of nanomedicine is the lack of sufficient and suitable data to estimate the environmental and the health risks associated with nanomedicine products. This is particularly the case for the human health risks, since from the inventory made in a pilot report on “EHS issues of selected nanomaterial values chains and their market prospects”, it appears that environmental risks are probably low. A key mitigating factor is that, even if nanomaterials were to be widely used in medical applications, the total tonnage of materials used will be small.